RC108-ADC

· RemeGen Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RC108-ADC, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor [Phase 2]